The bill authorizes prescribers and pharmacists in Wyoming to prescribe and dispense medications for off-label indications, which refers to the use of FDA-approved drugs for treatments not specified in their labeling. It establishes definitions for key terms such as "disciplinary action," "off label indication," "pharmacist," and "prescriber." The bill also provides that prescribers and pharmacists will not face adverse actions from health-related licensing boards or employers solely based on their decisions to prescribe or dispense medications for off-label use. Additionally, it specifies that recommendations or treatments related to COVID-19 that are not endorsed by health authorities will not be deemed unprofessional conduct.

Furthermore, the bill grants civil immunity to prescribers and pharmacists for any damages or penalties arising from their actions taken in accordance with the provisions of this article. This immunity is designed to protect healthcare professionals when they are acting within the scope of the law as outlined in the bill. The act is set to take effect on July 1, 2023.